Supriya Lifescience Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Apr '25 Apr 2, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	2018 - 2019
Market Capitalization	63,292	26,797	15,352	39,702	-	-	Upgrade
Market Cap Growth	135.04%	74.55%	-61.33%	-	-	-	Upgrade
Enterprise Value	62,504	25,696	13,821	39,457	-	-	Upgrade
Last Close Price	786.40	332.51	190.11	490.81	-	-	Upgrade
PE Ratio	36.30	22.50	17.09	26.15	-	-	Upgrade
PS Ratio	9.45	4.70	3.33	7.49	-	-	Upgrade
PB Ratio	7.02	3.29	2.19	6.45	-	-	Upgrade
P/TBV Ratio	6.59	3.29	2.20	6.46	-	-	Upgrade
P/OCF Ratio	23.65	24.14	81.36	-	-	Upgrade
EV/Sales Ratio	9.32	4.51	3.00	7.44	-	-	Upgrade
EV/EBITDA Ratio	24.81	14.67	10.79	18.47	-	-	Upgrade
EV/EBIT Ratio	26.77	16.04	11.80	19.31	-	-	Upgrade
Debt / Equity Ratio	0.01	0.01	0.03	0.05	0.27	0.57	Upgrade
Debt / EBITDA Ratio	0.02	0.03	0.17	0.13	0.42	0.79	Upgrade
Debt / FCF Ratio	-	-	-	-	2.61	0.92	Upgrade
Asset Turnover	-	0.66	0.59	0.90	1.00	1.09	Upgrade
Inventory Turnover	-	2.31	1.89	2.47	2.18	3.64	Upgrade
Quick Ratio	-	2.46	2.60	3.47	1.12	0.80	Upgrade
Current Ratio	-	5.17	4.85	4.99	1.82	1.27	Upgrade
Return on Equity (ROE)	-	15.73%	13.66%	34.34%	59.17%	60.42%	Upgrade
Return on Assets (ROA)	-	11.50%	9.42%	21.64%	26.60%	21.38%	Upgrade
Return on Capital (ROIC)	17.47%	12.98%	10.73%	25.96%	36.20%	30.01%	Upgrade
Return on Capital Employed (ROCE)	-	19.00%	16.20%	32.20%	55.60%	55.70%	Upgrade
Earnings Yield	2.76%	4.45%	5.85%	3.82%	-	-	Upgrade
FCF Yield	-1.21%	-2.89%	-0.28%	-	-	Upgrade
Dividend Yield	0.10%	0.24%	0.32%	0.12%	-	-	Upgrade
Payout Ratio	0.00%	4.05%	5.37%	2.89%	3.20%	24.04%	Upgrade
Buyback Yield / Dilution	-0.14%	-	-	-9.97%	-	-	Upgrade
Total Shareholder Return	-0.04%	0.24%	0.32%	-9.85%	-	-	Upgrade

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.